This document discusses nerves and muscles. It begins by describing the normal structure of peripheral nerves, including nerve fibers, myelin sheaths, and fascicles. It then discusses the pathology of segmental demyelination and axonal degeneration, which can lead to regeneration or reinnervation of muscles. Various diseases of peripheral nerves are also summarized, including inflammatory, traumatic, metabolic, toxic, genetic, and neoplastic neuropathies. Spinal muscular atrophy is provided as an example of a disease causing denervation atrophy of skeletal muscles in early childhood.
Myopathies - In detail (Classification and images) Dr. Tushar Kariya
In this presentation I've tried to cover myopathies, its classification and related images with H&E and special stain wherever its possible. Hope it helps you guys to understand the entity better.
Myopathies - In detail (Classification and images) Dr. Tushar Kariya
In this presentation I've tried to cover myopathies, its classification and related images with H&E and special stain wherever its possible. Hope it helps you guys to understand the entity better.
Peripheral neuropathy (PN) is damage to or disease affecting nerves, which may impair sensation, movement, gland or organ function, or other aspects of health, depending on the type of nerve affected
multiple sclerosis is an auto immune disease affecting the brain and spinal cord
Multiple sclerosis (MS) or disseminated sclerosis is characterized by chronic inflammation, demyelination, and scaring of the myelin sheath of the CNS. Myelin damage disrupts communication between your brain and the rest of your body. Ultimately, the nerves themselves may deteriorate, a process that's currently irreversible
The cause of multiple sclerosis is unknown. It is believed to be an autoimmune disease, in which the body's immune system attacks its own tissues.
Early Symptoms of MS
• Blurred or double vision
• Thinking problems
• Clumsiness or a lack of coordination
• Loss of balance
• Numbness
• Tingling
• Weakness in an arm or leg
No two people have exactly the same symptoms of MS.
You may have a single symptom, and then go months or years without any others. A problem can also happen just one time, go away, and never return. For some people, the symptoms become worse within weeks or months.
Common Symptoms of MS
These are the most common changes to the mind and body in someone with MS:
Unusual sensations: People with MS often say they feel a "pins and needles" sensation. They may also have numbness, itching, burning, stabbing, or tearing pains. About half of people with MS have these uncomfortable symptoms. Fortunately, they can be managed or treated.
Bladder problems: About 8 in 10 people have bladder problems, which can be treated. You may need to pee often, urgently, need to go at night, or have trouble emptying your bladder fully. Bowel problems, especially constipation, are also common.
Trouble walking: MS can cause muscle weakness or spasms, which make it harder to walk. Balance problems, numb feet, and fatigue can also make walking hard.
Dizziness: It's common to feel dizzy or lightheaded. You usually won't have vertigo, or the feeling that the room is spinning.
Fatigue: About 8 in 10 people feel very tired. It often comes on in the afternoon and causes weak muscles, slowed thinking, or sleepiness. It's usually not related to the amount of work you do. Some people with MS say they can feel tired even after a good night's sleep.
Muscle spasms: They usually affect the leg muscles. For about 40% of people they are an early symptom of MS. In progressive MS, muscle spasms affect about 6 in 10 people. You might feel mild stiffness or strong, painful muscle spasms.
Sexual trouble: These include vaginal dryness in women and erection problems in men. Both men and women may be less responsive to touch, have a lower sex drive, or have trouble reaching orgasm.
Speech problems: Sometimes MS can cause people to pause a long time in between words and have slurred or nasal speech. Some people also develop swallowing problems in more advanced stages of MS.
Motor neuron disease is a rare disease it doesn't have any cure here in this video I have tried playing what is mnd its types causes how to diagnose and its management plan
Peripheral neuropathy (PN) is damage to or disease affecting nerves, which may impair sensation, movement, gland or organ function, or other aspects of health, depending on the type of nerve affected
multiple sclerosis is an auto immune disease affecting the brain and spinal cord
Multiple sclerosis (MS) or disseminated sclerosis is characterized by chronic inflammation, demyelination, and scaring of the myelin sheath of the CNS. Myelin damage disrupts communication between your brain and the rest of your body. Ultimately, the nerves themselves may deteriorate, a process that's currently irreversible
The cause of multiple sclerosis is unknown. It is believed to be an autoimmune disease, in which the body's immune system attacks its own tissues.
Early Symptoms of MS
• Blurred or double vision
• Thinking problems
• Clumsiness or a lack of coordination
• Loss of balance
• Numbness
• Tingling
• Weakness in an arm or leg
No two people have exactly the same symptoms of MS.
You may have a single symptom, and then go months or years without any others. A problem can also happen just one time, go away, and never return. For some people, the symptoms become worse within weeks or months.
Common Symptoms of MS
These are the most common changes to the mind and body in someone with MS:
Unusual sensations: People with MS often say they feel a "pins and needles" sensation. They may also have numbness, itching, burning, stabbing, or tearing pains. About half of people with MS have these uncomfortable symptoms. Fortunately, they can be managed or treated.
Bladder problems: About 8 in 10 people have bladder problems, which can be treated. You may need to pee often, urgently, need to go at night, or have trouble emptying your bladder fully. Bowel problems, especially constipation, are also common.
Trouble walking: MS can cause muscle weakness or spasms, which make it harder to walk. Balance problems, numb feet, and fatigue can also make walking hard.
Dizziness: It's common to feel dizzy or lightheaded. You usually won't have vertigo, or the feeling that the room is spinning.
Fatigue: About 8 in 10 people feel very tired. It often comes on in the afternoon and causes weak muscles, slowed thinking, or sleepiness. It's usually not related to the amount of work you do. Some people with MS say they can feel tired even after a good night's sleep.
Muscle spasms: They usually affect the leg muscles. For about 40% of people they are an early symptom of MS. In progressive MS, muscle spasms affect about 6 in 10 people. You might feel mild stiffness or strong, painful muscle spasms.
Sexual trouble: These include vaginal dryness in women and erection problems in men. Both men and women may be less responsive to touch, have a lower sex drive, or have trouble reaching orgasm.
Speech problems: Sometimes MS can cause people to pause a long time in between words and have slurred or nasal speech. Some people also develop swallowing problems in more advanced stages of MS.
Motor neuron disease is a rare disease it doesn't have any cure here in this video I have tried playing what is mnd its types causes how to diagnose and its management plan
Peripheral nerve injuries-ASSESSMENT AND TENDON TRANSFERS IN RADIAL NERVE PALSYsuchitra_gmc
A presentation to understand peripheral nerve injuries assessment, evaluation and management. Includes principles of tendon transfer and techniques of tendon transfer for radial nerve palsy. Also, post operative rehabilitation is included.
Ocular nerve palsies are tricky to understand and are confusing. Learning the features by correlating with the anatomy make it easy.
These are both congenital and acquired.
With differential diagnosis and by proper stepwise ocular evaluation takes us to final diagnosis.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
2. Normal nerve
Principal structural components
Nerve fibre – axons, schwann cells, myelin sheath
Groups of nerve fibres:- surrounded by connective tissue sheath is
a fascicle.
Myelinated nonmyelinated are intermingled
in a fascicle.
6. in this view of a transected equine sciatic nerve, epineurium (E) is present on the left side o of
Fibrous perineurium (red arrows) surrounds individual nerve fascicles.
Notice perineuralepithelium (green arrows) deep to the fibrous perineurium (see Fig. 8).
The endoneurium surrounding individual myelinated fibers within the fascicle is barely evident
at this magnification.
11. Pathology
Schwan cells- segmental demyelination
Axons - axonal degeneration either can lead to
axonal regeneration or reinervation of the muscle.
The process affects some schwann cells sparing
others. The disintegrating meylin is engulfed by
initially schwann and then by macrophages. The cells
in endoneurium replace schwann cells. The new
internodes are shorter.
12.
13. Segmental demyelination
Dysfunction of schwann cells :- -as in guillain-barre
syndrome.
Damage to myelin sheath:- -e.g. hereditary motor and sensory
neuropathy.
There is no primary abnormality of axon.
14. With sequential episodes of de and
remyelination(onion bulbs)
Axonal degeneration and muscle fibre atrophy
primary destruction of the axon with secondary loss
of its myelin sheath
.
Damage to axon can be local (trauma or ischemia) or
more generalised affecting cell body or its axon
(neuronopathy or axonopathy).
15.
16. When axonal injury:-
e.g. traumatic transaction of a nerve, the distal
portion of fiber undergoes wallerian degeneration
_the axon begins to breakdown and the effected
schwann cells begin to catabolyze myelin and engulf
axon fragments forming small oval compartments
(myelin ovoids).
Macrophages phagocytose axonal and myelin debris.
The stump of proximal portion of the nerve shows
degenerative changes in distal two or three internodes
and then undergoes regenerative activity.
17. When axonal degeneration occurs the muscle fibers within the affected motor unit
lose their neuronal input and undergo denervation atrophy.
In cross section atrophic fibers are smaller and have a triangular shape.
Some muscles cells show disorganized filaments in the center of fiber (target fiber).
18. Nerve regeneration and reinnervation of
muscle
Proximal stumps of degenerated axons sprout and elongate
and the growth cones use schwann cells to guide them.
Presence of multiple closely aggregated thinly myelinated
small calibre axons is evidence of regeneration
It is a slow process_1mm per day.
Reinnervation of atrophic muscle fibers within an injured
motor unit occurs when the axons belonging to an
unaffected neighboring motor unit extend sprouts to
reinnervate the deinnervated myosites and incorporate them
into the healthy motor unit.
19. Reactions of the muscle fiber
Segmental necrosis,
destruction of a portion of the length of
a myosite and infiltration by
macrophages result in loss of muscle
fiber the n deposition of collagen and fat
vacuolation,
alterations in structural protiens or organelles and accumalation
of intracytoplasmic deposits
20. Regeneration occurs from satelite cells.
The regenerating muscle fiber has a large internalized nucleus and prominent
nucleoli and the cytoplasm laden with RNA is basophilic.
Fiber hypertrophy
22. Inflamatory neuropathies
They can be either
1) Immune mediated or;
2) Infectious
Immune mediated
• Guillain-barre syndrome(acute inflammatory
demyelinating polyradiculopathy)
• Life threatening disease
• Weakness in distal limbs(ascending paralysis )
• Histologically --- -inflammation of peripheral nerves
Demyelination of spinal nerve roots
23. Pathogenesis
2/3of cases are preceded by acute influenza like illness from
which patients recover and then symptoms appear.
Infections associated with G B;
Compylobacter jejuni.
Cytomegalo virus.
Ebstienebar virus.
Mycoplasma pneumoniae.
No consistant demonstration of infectious agent so
immunological reaction is favoured as the underlying cause.
Experimental proof of its being imunological reaction are
there.
24. Morphology
Perivenular and endoneurial infilteration by
lymphocytes,macrophages and a few plasma
cells.
Inflammatory cells may be sparse around
perivenous spaces or large throughout the
nerve
.
demyelination, primary lesion but damage to
axon is also characteristic in severe cases.
25. Clinical Course
Ascending paralysis.
Deep tendon reflexes disappear.
Sensory involvement detected but is less troublesome.
Nerve conduction velocity slowed.
Increased protein in CSF.
Patients spend weeks in hospital but recover normal functions with
improved respiratory care and support.
26. Infectious Polyneuropathies
Leporacy
Periphral nerves involvement in both lepromatous and
tuberculoid.
In lepromatous schwann cells are invaded by mycobacterium
laprae which proliferates and infects other cells.
There is segmental demyelination and remyelination and loss of
axons.
There is endoneurial fibrosis and multilayered thickening of the
perineurial sheaths.
27. Symmetric polyneuropathy that involves pain fibres:
– loss of sensation contributes to traumatic ulcers in
extremities.
Tuberculoid leprosy shows active cell mediated immune
response with nodular granulomatous inflammation in
dermis which injures cutaneous nerves in the vicinity :–
axons, schwann cells and myelin are lost
Fibrosis of perineurium and endoneurium.
Much more localized nerve involvement.
28. Diphtheria
Peripheral nerve involvement – dephtheria exotoxin.
Paresthesias, weakness, early loss of proprioception and
vibratory sensations.
Earliest changes seen in sensory ganglia because toxin enters
as there is incomplete blood nerve barrier.
There is segmental demyelination of axons of anterior and
prosteior roots and mixed nerves.
29. Varicella-zoster virus
• Most common virul infection of periphral nervous
system.
• Latent infection of neurons in sensory ganglia after
chicken pox.
• Reactivation – painful vasicular skin eruptions –
thoracic and trigeminal.
• Ganglia show neuronal destruction and loss,
mononuclear infiltrate, nicrosis and hemorrhage is
found.
• Peripheral nerves show axonal degeneration.
• Focal destruction if large motor neurons of anterior
horn or cranial nerve motor nuclei at corresponding
levels.
30. Hereditary Neuropathies
Heterogeneous, progressive and disabling syndromes affecting peripheral nerves.
They can be divided into several groups:
1. Hereditary motor and sensory neuropathies
( HMSN)
2. Hereditary sensory and autonomic
neuropathies (HSAN)
3. Familial amyloid polyneuropathy
4. Peripheral neuropathy accompanying
inherited metabolic disorders
31. HMSN type 1
Most common heriditory hypertrophic form.
Presents in childhood or early adulthood.
Characteristic progressive muscular atrophy of the calf – peroneal muscular
atrophy.
Patients maybe asymptomatic but present with distal muscle weakness, atrophy of
calf or secondary orthopedic of the foot.
Autosomal dominant.
Limited in severity and normal lifespan.
Common charcot- marie- tooth disease,
32. Molecular genetics
Genetically heterogenous in HMSN 1A
Duplication of large region of chromosome 17 – segmental trisomy.
This segment includes gene for peripheral myelin protein 22.
HMSN 1B – chromosome 1 genetic locus involves myelin protein zero – identical clinical
phenotype.
Another group chromosome 16 – gene mutation involved in protein degradation.
Gene on chromosome X – gap junction protein connexin 32.
33. Morphology
CMT1 is a demyelinating neuropathy .
Demyelination and remyelination with multiple onion bulbs more in distal nerves.
Axon is present in center of onion bulbs thin myelin sheath.
Layers of schwann cell hyperplasia surrounding individual axons cause
enlargement of perpheral nerves which are palpable – hypertrophic neuropathy.
Autopsy shows degeneration of posterior columns of spinal cord.
34. HMSN 2
• Neuronal form autosomal dominant CMT2A
• Nerve enlargement not seen
• Signs and symptoms similar to HMSN1
• Linked to chromosome1.
• Nerve biopsy shows loss of myelinated axons
• These findings suggest primary cellular dysfunction is the
axon or the neuron.
35. HSMN 3 (Dejerine - Sottas
disease)
Slowly progressive autosomal reccessive disorder.
Begins in early childhood manifested by delaying
developmental milestones.
Both trunk and limb muscles are involved.
Enlarged peripheral nerves can be detected.
Deep tendon reflexes depressed, nerve conduction
velocity slowed.
Heterogenous – same genes involved as in HSMN1
Size of peripheral nerve fasicicles is increased with
abundant onion bulb formation and segmental
demyelination.
36. Aquired metabollic and toxic
neuropathiesAdult – onset diabetes mellitus
•Depends upon duration of disease
•25 years of diabetes – 50% of patients clinically have peripheral neuropathy and 100% have
conduction abnormalities electrophysiologicaly.
•Clinicopathological patterns of nerve abnormalities are—distal symmetric sensory or
sensorimotor neuropathy, autonomic neuropathy and focal or multifocal asymmetric neuropathy.
37. Morphology
• Symmetric sensorimotor neuropathy---axonal neuropathy, some segmental
demyelination.
• Loss of small myelinated and nonmyelinated fibres but large fibres are also
affected.
• Endoneurial arterioles show thickening, hyalinization and intence PAS positivity in
their walls.
• Extensive reduplication of the basement membrane.
38. Clinical course
Most common peripheral neuropathy is the symmetric
neuropathy that involves distal sensory and motor nerves.
Decreased sensation, loss of pain, ulcers.
Dysfunction of autonomic nervous system.
39. Metabolic and nutritional peripheral
neuropathies
Renal failure-uremic neuropathy- distal symmetric
neuropathy may be asymptomatic or muscle cramps,
distal dysesthesias, diminished deep tendon reflexes
axonal degeneration- primary event
Regeneration and recovery common after dialysis
Thiamine deficiency- axonal- neuropathic beri beri
Vit B 12, B 6 and E- axonal neuropathies
Chronic liver, respiratory and thyroid disease-
peripheral neuropathy
Associated with malignancies
Industrial toxins
41. Tumors of peripheral nerves
Schwannoma-arise from neural crest derived schwann cells
and are associated with neuro fibro mstosis type 2
Mutations in NF2 gene chromosome 22
Common location cerebello pontine angle- attached to the
vestibular branch of the 8th
nerve
Patients present with tinnitus, hearing loss (acoustic neuroma,
vestibular schwannoma)
Extra dural associated with large nerve trunks
42. Morphology
Well circum scribed, encapsulated masses attached to
the nerve but can be separated
Firm gray masses may have cystic and xanthomatous
change
Microscopically Antoni A pattern- elongated cells
with cytoplasmic processes are arranged in fascicles
in areas of moderate to high celularity with little
stromal matrix; the nuclear free zones of processes
that lye between the regions of nuclear palisading are
termed verocay bodies
43. Antoni B pattern of growth-less densely cellular, loose mesh
work of cells with micro cysts with myxoid change.
Cell shape in both areas is elongated with regular oval nuclei
S-100 positive
44. Neurofibroma
2 type:
1. Cutaneous, solitary; arise
sporadically or with NF1- becomes
large and penduclated. Malignant
trasnformation small-cosmetic
concerns.
2. Plexiform-NF1, difficulty in surgical
removal when large trunks are
involved since they have significant
potential for malignant
transformation
45. Morphology
Cutaneous neurofibroma; present in dermis and subcutaneous
fat, well delineated unencapsulated masses composed of
spindle cells
Non-invasive but sometimes
enwrap, adnexal structures.
Stroma is highly collagenized
46. Plexiform neurofibroma
Anywhere along the nerve, large nerve trunk is
most common sight
Multiple, nerve is irregularly expanded as each of
its fascicles is infiltrated by the neoplasm
Nerve cannot be separated
Poorly defined margins
Microscopy- loose myxoid background with low cellularity. Cells are schwann cells,
fibroblasts, inflammatory cells. Shredded collagen.
51. Normal Skeletal Muscle
• Two major types of fibres:
Type 1 and Type 2 based on histochemistry and physiology.
Type 1:
• Type 1 fibres are high in myoglobin and oxidative enzymes, have many
mitochondria, perform tonic contractions, dark staining for adenosine
triphosphatase at pH4.2 but light stain at pH9.4.
52. Type 2 fibres are rich in glycolytic, enzymes ,rapid phasic contractions, they are dark
staining on ATPase performed at ph 9.4 and light stain at ph 4.2.
Motor neuron determines fibre type.
All fibres of a single unit are of the same type.
Fibres of a single motor unit are distributed across the muscles, giving rise to a checkerboard
pattern.
Endomysium, perimysium and epimysium.
53. Diseases of skeletal muscles
• Denervation atrophy.
• Either affects the anterior horn cells or its axons.
Spinal muscular atrophy[infantile motor neuron
disease].
• Progressive neurological illnesses.
• Affects anterior horn cells , cranial motor neurons
resulting in their loss.
• Spinal muscular atrophy(SMA).----a distinctive group
of autsomal recessive motor neuron diseases that
begin in childhood or adolescence.
54. SMA is considered with chilhood myopathies. Its
pathological findings in skelatal muscle are
characteristic.
Genetics
survival motor neuron gene on chromosome 5.
Homozygous deletion—in 90% of SMA
Deletion of neuronal apoptosis inhibitory gene----
associated with severe clinical phenotype.
55. Spinal muscular atrophy with groups of atrophic
muscle fibers resulting from denervation atrophy
of muscle in early childhood.
56. Morphology
Large no of atrophic fibres –a few micrometres in
diameter .unlike groups of angulated atrophic fibres
seen in denervation atrophy of muscles in adult.
Panfascicular atrophy.
Large fibres 2-4 times normal.
57. Clinical course
SMA type 1—most common(werdnig-
hoffman) –onset at birth or within 4
months—leads to death –3 yrs. Of life
.
SMA type2-SMA type 3.—present later
—survive till later ages.
58. Muscular dystrophies
Inherited disorders –hetrogenous-beginning in
childhood.
Progressive muscle weakness and wasting.
Histologicaly—advanced cases –replacement by
fibrofatty tissue.
59. X linked muscular dystrophy (duchenne and
becker)
DMD-most common and severe 1 in 3500 male.
Clinically manifest by 5yrs.---
weakness – wheelchair --10—12yrs of age. Progressive death by 20s.
BMD –less common –less severe –same genetic
locus.
63. Aim is to:
1.Minimize the development of contractures and
deformity by developing a program of stretches
and exercises where appropriate
2.Anticipate and minimize other secondary
complications of a physical nature
3.Monitor respiratory function and advice on
techniques to assist with breathing exercises
and methods of clearing secretions
4.Schedule weekly to monthly sessions at a
massage therapist to decrease the present
pain.
64. Dystrophin, an intracellular protein, forms an interface between the cytoskeletal proteins and a group of
transmembrane proteins, the dystroglycans and the sarcoglycans. These transmembrane proteins have interactions
with the
extracellular matrix, including the laminin proteins. Dystrophin also interacts with dystrobrevin and the syntrophins,
which form a link with neuronal-type nitric oxide synthetase(nNOS) and caveolin. Mutations in dystrophin are
associated with the X-linked muscular dystrophies, mutations in caveolin and the sarcoglycan proteins with the
autosomal limb girdle
muscular dystrophies, and mutations in the a2-laminin (merosin) with a form of congenital muscular dystrophy
65. Pathogenesis and genetics
DMD- BMD-CAUSED BY;
Abnormality in gene located on X chromosome—
encodes 427kd pr.-Dystrophin.
Deletions—commonest.
Frameshift and point mutations-for the rest.
2/3 familial. rest new mutations.
Females –carriers—asymptomatic –
increased serum cretine kinase
risk of dilated cardiomyopathy.
66. Dystrophin –cytoplasmic pr.near plsmemembrane over Z-
band-forms strong link to Actin.
Forms an interface b.w intracellular contractile apparatus
and extracellular c.t matrix
DMD –muscle biopsy –staining and western blot
--minimum dystrophin.
BMD –diminished dystrophin –abnormal m.w
67. A, Duchenne muscular dystrophy (DMD) showing variation in muscle fibersize,increased
endomysial connective tissue, and regeneratingfiber(bluhue) B –Western blot showing
absence of dystrophin in DMD and altered dystrophin size in Becker muscular dystrophy
(BMD) compared with control
68. Morphology
Abnormalities common to DMD BMD
Variation in fiber size due to small and large fibers –fiber
splitting.
Internalized nuclei.
Degeneration, necrosis &phagocytosis.
Regeneration of muscle fibers.
Proliferation of endomysial c.t.
69. DMD—cases show enlarged rounded hyaline fibres
–lost cross stiations—hypercontracted.
.Both type 1,2 fibres involved.
Later stages –muscles replased by fat c.t.
Cardiac interstisial fibrosis in subendocardial layer.
Clinical evidence of CNS dysfunction in DMD no
pathologgical abnormality.
70. Clinical course
Boys with DMD are normal at birth– early
motor milestones met on time.
Walking delayed, clumsiness inability to
keep up with peers.
Weakness in pelvic girdle muscles and then
extend to shoulder muscles.
Pseudohypertrophy– calf muscle.
Cardiomyopathy-.
Cognitive impairment.
71. Serum creatine kinase -----elevated in beginning –
later decrease.
Death ------–respiratory insufficiency,pulmonary
infection,cardiac decomposition.
Gene therapy------- hampered by the size of gene.
Experimental animal ------–2 delivery systems.
One---stem cell inj. In muscle.
Second---engineerd gene which produces normal
dystrophin carried by adeno virus is injected.
72. Boys with BMD develop symptoms at later age .
Onset in late childhood slower and variable rate of
progression.
Many pt. have anormal life span.
73. Other Muscular Dystrophies
Less common.
Have distinct clinical and pathological
features.
Limb girdle muscular dystrophies;
Type 1---autosomal dominant—six sub types
Type 2---autosomal recessive—11 sub types
Mutation of sacroglycan complex of
protiens in 4 LGMD 2C,2D,2E,2F.
74. Myotonic Dystrophy
MYOTONIA---the sustained involuntary contraction
of a group of muscles.
pt. complains of stiffness and have dificulty in
releasing their grip e.g. handshake.
Myotonia can be elicited by thenar percussion
75. Pathogenisis
Autosomal dominant.
CTG trinucleotide repeat expansion on
chromosome 19.
mRNA of dystrophia myotonia pr.kinase is
affected.
In normal subjects fewer than 30 repeats.
Expansion of these repeats----disease several
thousand repeats in severely affected.
Phenomenon of anticipation.
76. Morphology
Variation in fibre size.
Striking increase in no.of intrnal nuclei—
conspicuous chain on l.section.
Ring fibre---subsarcolemal band of cytoplasm
—contains myofibrils arranged
circumferentialy. Irregular mass of cytoplasm
extending from ring fibre is (sarcoplasmic
mass).
Only myotonic dystrophy shows changes in
intrafusal fibres of muscle spindle, splitting
,necrosis ,regeneration.
77. Clinical course
Presents in childhood with abnormalities in
gait secondary to weakness of foot
dorseflexors.
Progresses to weakness of hand intrinsic
musclesand wrist extensors.
Atrophy of muscles of face ptosis—typical
facial appearance.
Cataracts detected early.
Frontal balding ,gonadal
atrophy,cardiomyopathy,smooth muscle
involvement,decreased plasma IgG.
78. Ion Channel Myopathies
Group of familial diseases.
Myotonia .
Relapsing episodes of hypotonic
paralysis(after vigorous exercise,cold or
high carb. Meal.)or both.
Hyperkalemic,hypokalemic and
normokalemic periodic paralysis.
79. Pathogenesis
Mutations in genes encoding ion
channels.
Hyperkalemic periodic paralysis—gene
mutation encoding sodium channel pr.
(SCN4A) which regulates entry of
sodium in muscle during contraction.
Hypokalemic—gene encoding voltage
gated L-type calcium channel.
80. Malignant hyperpyrexia;
A rare clinical syndrome –tachycardia,tachypnia
,muscle spasm ,hyperpyrexia .----triggered by
anesthetics---.
Syndrome occurs in predisposed individuals with
heriditory muscle diseases ----congenital
myopathies,dystrophinopathies,metabolic
myopathies.
Upon exposure to anesthetics –uncontrolled eflux of
Ca+ from sarcoplasm—tetany ,increased muscle
metabolism ,heat production.
81. Congenital Myopathies
Group of disorders defined largely on basis of
pathological findings within muscles.
Share common clinical features---early onset,non or
slowly progressive,proximal or generalised muscle
weakness ,and hypotonia.
Floppy infants –hypotonia or joint
contractures(arthrogryposis) ---both these things can be
caused by neuromuscular dysfunction.
List of these myopathies but Nemaline myopathy—one of
the most distinctive types shows numerous rod shaped
intracytoplasmic inclutions-(materia of z band)
82. A, Nemaline myopathy with numerous rod-shaped, intracytoplasmic
inclusions (darkpurple structures). B, Electron micrograph
ofsubsarcolemmalnemalinebodies,showingmaterial of Z-band density.
83. Myopathies of inborn errors of
metabolism
Lipid myopathies:
Block in fatty acid oxidation and accumulation
of lipid droplets within muscle.
There is abnormality of carnitine transport or
deficiency of mitochondrial dehydrogenase
system.
Pt. develop muscle pain
,tightness,myoglobinuria after execise or
fasting.
Cardiomyopathy and fatty liver may occur.
84. Mitochondrial myopathy
(oxidative phosphorylation
diseases).
1/5of pr.involved in oxidative
phophorylation are encoded in mt.DNA
mtDNA also encodes 22 transfer RNA and
2ribosomal RNA.
rest of mt.enzymes are encoded in nucleus.
Mitochondrial myopathies.--
Mt.DNA –maternal inheritance as oocyte
contributes mitochondria to embryo.
85. 13 A, Mitochondrial myopathy showing an irregular fiber with
subsarcolemmal collections of mitochondria that stain red with the
modified Gomori trichrome stain (ragged red fiber). B, Electron
micrograph of mitochondria from biopsy specimen in A showing "parking lot"
inclusions.
86. Mitochondrial disease –present young adulthood –
proximal muscle weakness –extraocular muscles
(external ophthalmoplegia)
Nurological symptoms
Lactic acidosis
Cardiomyopathy
All above are called mt.enchephalomyopathies.
87. Morphology
• Aggregates of abnormal mitochondria in muscle biopsy.
• In early stages under sarcolema ,then extends throughout
the fibre.
• Distortion of myofibrils so fibre contour irregular on
crossection----ragged red fibres.
• E M –increased no. of mt. irregular shape
• Paracrystaline parking lot inclusions or alteration in
structure of cristae
• Cytochrome oxidase –negative fibres.
88. Clinical Course & Genetics
3 types of mutations:
1.pt.mutations in mt. DNA.
2.mutations in nuclear DNA.
3.deletions or duplication of mt. DNA.
89. Inflammatory Myopathies
• 3 groups of these:
1. Infections
2. Non infectious inflammatory
3. Systemic inflammatory.
Non infectious inflammatory
Heterogeneous gp. of disorder
• Immune mediated characterized by injury &inflammation
90. • 3 disorders :
1.dermatomyositis
2.polymyositis
3. inclusion body myositis.
Dermatomyositis
Inflammation of skin and muscles.
Skin rash accompany or precede onset of muscle
disease.
Lilac or heliotrope discoloration of upper eye lids with.
Periorbital edema.
91. Dermatomyositis. Note the rash affecting the eyelids. B,
Dermatomyositis. The histologic appearance of muscle shows
perifascicular atrophy of muscle fibers and
inflammation. C, Inclusion body myositis showing a vacuole within
a myocyte.
92. --
Scaling erythmatous eruptions or dusky red patches
over knuckles ,elbows knees(grotton lesions).
Muscle weakness slow in onset bilaterally
symmetrical accompanied by myalgias.
Affects proximal muscles first.—getting up of chair
,climbing stairs –difficult.
Fine movements affected late.
Dysphagia in1/3 of pt.
Interstitial lung disease ,vasculitis myocarditis may
be present in some.
Higher risk of cancers.
93. Polymyositis
•It differs from dermato. By lack of cutaneous
involvement and it is mainly in adults.
•There may be heart lung and b.v involvement.
Inclusion body myositis
• Begins with involvement of distal muscles –especially
extensors of knee(quadriceps)
•And flexors of wrist ,fingers.
•Weakness asymmetrical
•Slow development over age 50
•Most sporadic –familial also present
94. Etiology & Pathogenesis
In dermato. Capillaries target . Deposits of antibodies
comliment in b.v.B cells ,CD4+Tcells present within
muscle.
Polymyositis cell mediated injury to
musclers.CD8+Tcells ,macrophages near muscle.expession
of HLA class1,11 molecules increased on sarcolemma of
normal muscle.
Antinuclear antibodies present in some cases.
Inclusion body –less clear same as poly.but not respond to
immunosuppressive therapy. Ammyloid pr. Tau pr. Related
to age ,like Alzheimer.
95. Morphology
Dermato:
Inflammatory infilterate arround by and in perimysial c.t .
Gps.of atrophic fibres prominent at periphery of
fascicles(sufficient for diagnosis)
Marked reduction in intramuscular capill.
Necrotic muscle and regenerating also seen.
96. Polymyositis---inflammatory cells are in endomyceum
.CD8+lymphos. Surround and in vade healthy muscle
.necrotic and regenerating fibres seen throughout fascicles.
No bv injury.
Inclution body—presence of rimmed vacuoles within
myosites highlighted by basophilic granules at their
periphery.
amyloid deposits stain with congo red . Inflamatory
infilterate same as in poly.
97. Dignosis---EMG—informative.
Clinical symptoms
elevated creatine kinase
Biopsy—for definitive dignosis.
Immunosupressive therapy benificial in adults and
juvenile dermato.and in poly but not in inclusion body.
99. Ethanol myopathy:
Acute toxic syndrome—rhabdomyolysis –
myoglobinuria---renal failure.
Pain muscles ---on histo. Necrosis phagocytosis,
regeneration ,evidence of denervation.
Drug induced myopathy;
steroid myopathy ---proximal muscle weakness in
cushings syndrome or therapeutic use ;affects tyype 2
fibers.
chloroquin---proximal myopathy.presence of
vacuoles in myocytes 50% of fibers. type 1.
100. Diseases of neuromuscular
junction
• Myasthenia gravis:
autoimmune mediated loss of acetylecholine
receptors.
1-in 100,000.
before 4o yrs. Common in women.older age equal
occurance.
thymic hyperplasia in 65% of patients.
thymoma in15% of patients.